「泰福-KY」泰福-KY（6541）投资价值分析：生技医疗潜力股，盈利能力增强，投资需谨慎
泰福-KY基本情况
情況介紹
- 公司名稱：泰福生技股份有限公司
- 股票代號：6541
- 產業類別：生技醫療業
- 上市日期：2017/10/26
- 主要經營業務：生物相似藥及新藥之研發、製造及銷售
- 實收資本額：新台幣1,640,713,670元
- 公司網址：www.tanvex.com
- 公司發言人：陳林正
股本股東分析
營運能力分析
- 成交股數與收盤價：| 日期 | 成交股數 | 收盤價 |
| — | — | — |
| 11/29 | 1,117,916 | 72.3 |
| 12/2 | 575,532 | 72.0 |
| 12/3 | 599,507 | 73.6 |
| 12/4 | 451,333 | 72.3 |
| 12/5 | 304,729 | 71.6 |
| 12/6 | 602,727 | 69.5 |
| 12/9 | 301,223 | 68.0 |
| 12/10 | 161,968 | 67.0 |
| 12/11 | 183,717 | 65.7 |
| 12/12 | 283,772 | 64.2 |
| 12/13 | 209,975 | 63.1 |
| 12/16 | 310,016 | 61.0 |
| 12/17 | 105,336 | 62.0 |
| 12/18 | 93,962 | 62.4 |
| 12/19 | 158,679 | 61.4 |
| 12/20 | 148,066 | 60.8 |
| 12/23 | 139,259 | 61.1 |
| 12/24 | 50,576 | 61.4 |
| 12/25 | 162,996 | 61.4 |
| 12/26 | 124,913 | 62.0 |
| 12/27 | 119,698 | 62.1 |
| 12/30 | 120,791 | 63.5 |
| 12/31 | 218,941 | 65.2 |
| 1/2 | 103,038 | 64.7 |
| 1/3 | 148,944 | 62.9 |
| 1/6 | 313,271 | 64.1 |
| 1/7 | 197,632 | 64.1 |
| 1/8 | 89,155 | 64.5 |
| 1/9 | 172,019 | 62.7 |
| 1/10 | 271,700 | 65.5 |
- 買賣超情況：| 日期 | 外資及陸資買賣超 | 自營商買賣超 | 投信買賣超 |
| — | — | — | — |
| 11/29 | +249,000 | -2,000 | 0 |
| 12/2 | -48,000 | 0 | 0 |
| 12/3 | +290,000 | +2,000 | 0 |
| 12/4 | -103,000 | 0 | 0 |
| 12/5 | +24,000 | 0 | 0 |
| 12/6 | -141,000 | 0 | 0 |
| 12/9 | +42,697 | 0 | 0 |
| 12/10 | -5,000 | -1,000 | 0 |
| 12/11 | -50,000 | 0 | 0 |
| 12/12 | -78,000 | 0 | 0 |
| 12/13 | -851 | 0 | 0 |
| 12/16 | -74,000 | 0 | 0 |
| 12/17 | -37,500 | 0 | 0 |
| 12/18 | -25,000 | 0 | 0 |
| 12/19 | -29,000 | 0 | 0 |
| 12/20 | -58,000 | 0 | 0 |
| 12/23 | -32,000 | +4,000 | 0 |
| 12/24 | +9,000 | 0 | 0 |
| 12/25 | -46,000 | 0 | 0 |
| 12/26 | +3,000 | 0 | 0 |
| 12/27 | +1,000 | 0 | 0 |
| 12/30 | +30,000 | 0 | 0 |
| 12/31 | -29,000 | 0 | 0 |
| 1/2 | -34,000 | -9,000 | 0 |
| 1/3 | -45,000 | 0 | 0 |
| 1/6 | +51,000 | +4,000 | 0 |
| 1/7 | -9,000 | 0 | 0 |
| 1/8 | -3,000 | 0 | 0 |
| 1/9 | +1,000 | -4,000 | 0 |
| 1/10 | -1,000 | 0 | 0 |
- 融資融券情況：| 日期 | 融資張數 | 融券張數 |
| — | — | — |
| 11/29 | 0 | 0 |
| 12/2 | 0 | 0 |
| 12/3 | 0 | -2 |
| 12/4 | 0 | 0 |
| 12/5 | 0 | 0 |
| 12/6 | 0 | 0 |
| 12/9 | 0 | 0 |
| 12/10 | 0 | 0 |
| 12/11 | 0 | 0 |
| 12/12 | 0 | 0 |
| 12/13 | 0 | 0 |
| 12/16 | 0 | -20 |
| 12/17 | 0 | 0 |
| 12/18 | 0 | 0 |
| 12/19 | 0 | 0 |
| 12/20 | 0 | 0 |
| 12/23 | 0 | 0 |
| 12/24 | 0 | 0 |
| 12/25 | 0 | 0 |
| 12/26 | 0 | 0 |
| 12/27 | 0 | 0 |
| 12/30 | 0 | 0 |
| 12/31 | 0 | 0 |
| 1/2 | 0 | 0 |
| 1/3 | 0 | -1 |
| 1/6 | 0 | -3 |
| 1
所属行业状况分析
所在行业类型
生技醫療業
行业周期性
經濟周期
| 年度 |
繼續營業單位稅前淨利（千元） |
每股盈餘 |
| 2020 |
-2,104,212 |
-7.84 |
| 2021 |
-1,543,189 |
-4.74 |
| 2022 |
-1,641,107 |
-4.65 |
| 2023 |
-2,136,673 |
-16.58 |
| 2024 |
-1,103,022 |
-7.25 |
生命週期
| 年度 |
营收月 |
| 2020 |
0 |
| 2021 |
0 |
| 2022 |
911 |
| 2023 |
2,138 |
| 2024 |
2,063 |
行业竞争格局
| 日期 |
成交股數 |
收盤價 |
| 11/29 |
1,117,916 |
72.3 |
| 12/2 |
575,532 |
72.0 |
| 12/3 |
599,507 |
73.6 |
| 12/4 |
451,333 |
72.3 |
| 12/5 |
304,729 |
71.6 |
| 12/6 |
602,727 |
69.5 |
| 12/9 |
301,223 |
68.0 |
| 12/10 |
161,968 |
67.0 |
| 12/11 |
183,717 |
65.7 |
| 12/12 |
283,772 |
64.2 |
| 12/13 |
209,975 |
63.1 |
| 12/16 |
310,016 |
61.0 |
| 12/17 |
105,336 |
62.0 |
| 12/18 |
93,962 |
62.4 |
| 12/19 |
158,679 |
61.4 |
| 12/20 |
148,066 |
60.8 |
| 12/23 |
139,259 |
61.1 |
| 12/24 |
50,576 |
61.4 |
| 12/25 |
162,996 |
61.4 |
| 12/26 |
124,913 |
62.0 |
| 12/27 |
119,698 |
62.1 |
| 12/30 |
120,791 |
63.5 |
| 12/31 |
218,941 |
65.2 |
| 1/2 |
103,038 |
64.7 |
| 1/3 |
148,944 |
62.9 |
| 1/6 |
313,271 |
64.1 |
| 1/7 |
197,632 |
64.1 |
| 1/8 |
89,155 |
64.5 |
| 1/9 |
172,019 |
62.7 |
| 1/10 |
271,700 |
65.5 |
行业发展趋势
| 日期 |
外資及陸資買賣超 |
自營商買賣超 |
投信買賣超 |
| 11/29 |
+249,000 |
-2,000 |
0 |
| 12/2 |
-48,000 |
0 |
0 |
| 12/3 |
+290,000 |
+2,000 |
0 |
| 12/4 |
-103,000 |
0 |
0 |
| 12/5 |
+24,000 |
0 |
0 |
| 12/6 |
-141,000 |
0 |
0 |
| 12/9 |
+42,697 |
0 |
0 |
| 12/10 |
-5,000 |
-1,000 |
0 |
| 12/11 |
-50,000 |
0 |
0 |
| 12/12 |
-78,000 |
0 |
0 |
| 12/13 |
-851 |
0 |
0 |
| 12/16 |
-74,000 |
0 |
0 |
| 12/17 |
-37,500 |
0 |
0 |
| 12/18 |
-25,000 |
0 |
0 |
| 12/19 |
-29,000 |
0 |
0 |
| 12/20 |
-58,000 |
0 |
0 |
| 12/23 |
-32,000 |
+4,000 |
0 |
| 12/24 |
+9,000 |
0 |
0 |
| 12/25 |
-46,000 |
0 |
0 |
| 12/26 |
+3,000 |
0 |
0 |
| 12/27 |
+1,000 |
0 |
0 |
| 12/30 |
+30,000 |
0 |
0 |
| 12/31 |
-29,000 |
0 |
0 |
| 1/2 |
-34,000 |
-9,000 |
0 |
| 1/3 |
-45,000 |
0 |
0 |
| 1/6 |
+51,000 |
+4,000 |
0 |
| 1/7 |
-9,000 |
0 |
0 |
| 1/8 |
-3,000 |
0 |
0 |
| 1/9 |
+1,000 |
-4,000 |
0 |
| 1/10 |
-1,000 |
0 |
0 |
行业状况小结
公司财务状况分析
